<DOC>
	<DOCNO>NCT00364052</DOCNO>
	<brief_summary>Null Hypothesis : There significant difference incidence CMV infection use oral valganciclovir ganciclovir prophylactic anti-viral therapy . Alternate Hypothesis : There exist significant difference incidence CMV infection oral valganciclovir use CMV prophylaxis rather oral ganciclovir . A formal hypothesis test define .</brief_summary>
	<brief_title>Prophylactic Therapy Cytomegalovirus Liver Transplant Recipients</brief_title>
	<detailed_description>The objective retrospective clinical study describe incidence CMV infection orthoptic liver transplant recipient receive oral valganciclovir ganciclovir CMV prophylactic anti-viral therapy . Endpoints : Primary Endpoint CMV infection characterize viremia , syndrome disease abovementioned method one year post-transplantation . Secondary Endpoints 1 . Patient allograft survival base donor/recipient CMV status 2 . Incidence graft rejection loss associate CMV infection 3 . Time hepatitis C virus ( HCV ) occurrence 4 . Incidence HSV , EBV VZV reactivations 5 . Severity HCV occurrence base biopsy report base Knodell score 6 . Safety tolerability oral valganciclovir ganciclovir</detailed_description>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Valganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>All liver transplant perform Oregon Health &amp; Science University ( OHSU ) OHSU surgical medical staff treat patient . Portland Veterans Affairs Medical Center liver transplant recipient Patients decease within thirty day receive liver allograft Patients low risk acquire CMV infection : donornegative recipientnegative ( D/R ) Patients undergo retransplantation Lost followup ( minimum followup 1 year ) History CMV infection disease AntiCMV therapy within past 30 Severe , uncontrolled diarrhea evidence malabsorption .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Valganciclovir , Oral Ganciclovir , Liver transplant</keyword>
</DOC>